Drynaria roosii
Drynaria roosii
Drynaria roosii,一种原产于东亚的传统中药植物,主要用于草药疗法,并具有悠久的应用历史。尽管其具体的传统用途尚无明确记录,但研究表明从该植物提取物具有良好的前景。科学研究表明,Drynaria roosii 可以显著增加患有骨质疏松症的大鼠模型中的骨矿密度并改善皮质微结构,这可能对骨骼健康有益。此外,还发现它能减少铁积累和铁死亡相关的指标,加速骨缺损愈合,并增强与成骨有关的因素表达。该植物还能通过ITPR3激活促进牙槽窝愈合,增加钙流。然而,目前的研究有限,需要更多的人体研究来确认这些发现。尚未记录到主要的安全问题或药物相互作用,但鉴于其潜在的治疗益处,进一步调查是必要的。
- 最佳证据
- A
- 注意事项
- —
仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同,请查阅所引来源。
科学怎么说
- Drynaria roosii 提取物显著增加了大鼠骨质疏松模型中的骨矿密度并改善了皮质微结构。
- 使用TFRD和DMF的治疗减少了铁积累和与铁死亡相关的指标,加速了骨缺损愈合,并增强了与成骨相关的因素表达。
- 研究确定了在罗氏蕨(Drynaria roosii)中参与黄酮类化合物生物合成的关键基因,特别是在其根状茎中。
- 由Drynaria roosii衍生的类似外泌体纳米囊泡通过激活ITPR3促进牙槽窝愈合钙流增强。
Frequently asked questions
What is Drynaria roosii?
Drynaria roosii (Drynaria roosii) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Drynaria roosii?
4 sourced findings are recorded for Drynaria roosii; the strongest carries evidence grade A. For example: Drynaria roosii 提取物显著增加了大鼠骨质疏松模型中的骨矿密度并改善了皮质微结构。
How strong is the evidence for Drynaria roosii?
The strongest finding for Drynaria roosii carries evidence grade A — strong evidence. Grades run A (strongest) to D (preliminary or traditional).
Is Drynaria roosii safe? What are the side effects?
No major safety issues are recorded for Drynaria roosii in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Drynaria roosii interact with medications?
No drug interactions are recorded for Drynaria roosii in our sources. This does not rule them out — check with a pharmacist.
Is Drynaria roosii a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
来源
- T2 Integrative transcriptomic and metabolomic analysis of Drynaria roosii reveals genes involved in the biosynthesis of medicinal compounds. literature abstract metadata
- T2 Total flavonoids of Rhizoma drynariae targets NRF2-mediated anti-ferroptosis in osteoblasts to promote induced membrane osteogenesis. literature abstract metadata
- T2 Efficacy of Rhizoma Drynariae (Drynaria roosii Nakaike) extracts in treating osteoporosis in rat models: A systematic review and meta-analysis. literature abstract metadata
- T2 Drynaria roosii-derived exosome-like nanovesicles promote alveolar socket healing via activation of ITPR3-mediated calcium flux. literature abstract metadata